#Sun_Pharma
LightNews LightNews
newsen.bsky.social
Groundbreaking Treatment Guidelines for Adults with Severe Alopecia Areata Released by Experts#United_States#Princeton#Alopecia_Areata#Sun_Pharma#JAK_inhibitors
Groundbreaking Treatment Guidelines for Adults with Severe Alopecia Areata Released by Experts
Sun Pharma applauds the release of the U.S.'s first-ever standardized treatment recommendations for severe alopecia areata. These guidelines are set to transform patient care.
third-news.com
September 22, 2026 at 1:20 PM
newsen.bsky.social
Sun Pharma Teams Up with Designer Christian Siriano to Empower Those with Alopecia Areata#United_States#Princeton#Alopecia_Areata#Sun_Pharma#Christian_Siriano
Sun Pharma Teams Up with Designer Christian Siriano to Empower Those with Alopecia Areata
Sun Pharma and Christian Siriano launch "Regrowth Restyled," an initiative aimed at promoting self-expression among adults affected by severe alopecia areata through education and fashion.
third-news.com
September 17, 2026 at 12:38 PM
newsen.bsky.social
American Skin Association Honors Sun Pharma at Annual Gala with Leadership Award#USA#New_York#dermatology#American_Skin_Association#Sun_Pharma
American Skin Association Honors Sun Pharma at Annual Gala with Leadership Award
The American Skin Association's Annual Gala celebrated Sun Pharma's commitment to dermatology, highlighting their innovative efforts in skin health initiatives and research.
third-news.com
June 3, 2026 at 5:41 PM
newsen.bsky.social
Sun Pharma to Share Crucial Long-Term Data on UNLOXCYT at ASCO 2026 Annual Meeting#India#Mumbai#Sun_Pharma#UNLOXCYT#ASCO_2026
Sun Pharma to Share Crucial Long-Term Data on UNLOXCYT at ASCO 2026 Annual Meeting
Sun Pharmaceutical Industries will present significant long-term follow-up results of UNLOXCYT at the ASCO 2026 Annual Meeting. The data showcases efficacy in treating skin cancer.
third-news.com
May 26, 2026 at 2:20 PM
newsen.bsky.social
Investigation Launch: Ademi LLP Questions Fair Price for Organon Shareholders#USA#Milwaukee#Ademi_LLP#Sun_Pharma#Organon
Investigation Launch: Ademi LLP Questions Fair Price for Organon Shareholders
Ademi LLP is looking into Organon & Co.'s recent $14 per share transaction with Sun Pharma over fiduciary duty concerns. The investigation focuses on possible violations and implications for shareholders.
third-news.com
April 27, 2026 at 6:30 AM
newsen.bsky.social
Sun Pharma Showcases Major Research Advancements at 2026 AAD Annual Meeting#India#Mumbai#ILUMYA#Sun_Pharma#LEQSELVI
Sun Pharma Showcases Major Research Advancements at 2026 AAD Annual Meeting
At the 2026 AAD Annual Meeting, Sun Pharma presents 14 abstracts, showcasing advancements in the treatment of alopecia areata, psoriasis, and acne. The company emphasizes patient-centered care through meaningful scientific data.
third-news.com
March 27, 2026 at 2:56 PM
newsen.bsky.social
Sun Pharma's ILUMYA Receives FDA Review for Psoriatic Arthritis Treatment Expansion#USA#Princeton#ILUMYA#Sun_Pharma#Psoriatic_Arthritis
Sun Pharma's ILUMYA Receives FDA Review for Psoriatic Arthritis Treatment Expansion
Sun Pharma has announced that the FDA has accepted its application for ILUMYA, aiming to expand treatment options for adults with psoriatic arthritis, adding to its existing psoriasis indications.
third-news.com
March 16, 2026 at 11:15 AM
newsen.bsky.social
Sun Pharma Unveils New Findings on Dermatology and Immunology Products at Winter Clinical Miami 2026#United_States#Aventura#ILUMYA#Sun_Pharma#Winlevi
Sun Pharma Unveils New Findings on Dermatology and Immunology Products at Winter Clinical Miami 2026
At the 2026 Winter Clinical in Miami, Sun Pharma presents significant data across its dermatology and immunology offerings, showcasing innovations for patient care.
third-news.com
February 27, 2026 at 6:34 PM
newsen.bsky.social
Sun Pharma Launches SUNday Campaign for Everyday Skin Cancer Awareness and Care#India#Mumbai#Skin_Cancer#Sun_Pharma#SUNday
Sun Pharma Launches SUNday Campaign for Everyday Skin Cancer Awareness and Care
SUNday, a new initiative by Sun Pharma, aims to promote continuous awareness and support for skin cancer care, reflecting everyday realities.
third-news.com
February 5, 2026 at 1:26 PM
newsen.bsky.social
Sun Pharma Launches UNLOXCYT™, A New Treatment for Advanced Skin Cancer#United_States#Princeton#Sun_Pharma#UNLOXCYT#aCSCC
Sun Pharma Launches UNLOXCYT™, A New Treatment for Advanced Skin Cancer
Sun Pharmaceutical Industries has introduced UNLOXCYT™, a new option for treating advanced cutaneous squamous cell carcinoma in the U.S., offering significant benefits for patients.
third-news.com
January 15, 2026 at 7:20 PM
newsen.bsky.social
Sun Pharma Welcomes Jeremy Allen as New VP of Corporate Affairs for North America#USA#Princeton,_NJ#Corporate_Affairs#Sun_Pharma#Jeremy_Allen
Sun Pharma Welcomes Jeremy Allen as New VP of Corporate Affairs for North America
Sun Pharmaceutical Industries has appointed Jeremy Allen as the Vice President of Corporate Affairs for North America. He will lead key policy initiatives and strengthen stakeholder engagement in the region.
third-news.com
October 22, 2025 at 3:34 PM
newsen.bsky.social
Sun Pharma Launches LEQSELVI for Severe Alopecia Areata Treatment in the U.S.#United_States#Princeton#Alopecia_Areata#Sun_Pharma#LEQSELVI
Sun Pharma Launches LEQSELVI for Severe Alopecia Areata Treatment in the U.S.
Sun Pharmaceutical Industries has announced the U.S. launch of LEQSELVI, a new treatment option for adults with severe alopecia areata. This breakthrough offers hope for effective hair regrowth.
third-news.com
July 14, 2025 at 11:41 AM
newsen.bsky.social
Richard Ascroft Takes the Helm as CEO of Sun Pharma North America#United_States#North_America#Princeton#Sun_Pharma#Richard_Ascroft
Richard Ascroft Takes the Helm as CEO of Sun Pharma North America
Sun Pharma appoints Richard Ascroft as CEO for North America. With over 30 years of industry experience, he aims to enhance the company's innovative portfolio.
third-news.com
June 25, 2025 at 6:05 PM
newsen.bsky.social
Sun Pharma Receives FDA Approval for LED BLU-U® Blue Light Therapy for Actinic Keratosis#India#Mumbai#Sun_Pharma#BLU-U#Actinic_Keratosis
Sun Pharma Receives FDA Approval for LED BLU-U® Blue Light Therapy for Actinic Keratosis
Sun Pharma's LED BLU-U® device gains FDA approval for treating actinic keratosis, enhancing patient comfort with new design features.
third-news.com
May 16, 2025 at 1:15 PM
newsen.bsky.social
Sun Pharma and Moebius Medical Publish New Findings on MM-II for Osteoarthritis Pain Management#India#Mumbai#Sun_Pharma#Moebius_Medical#MM-II
Sun Pharma and Moebius Medical Publish New Findings on MM-II for Osteoarthritis Pain Management
Sun Pharma and Moebius Medical unveil two pivotal publications on MM-II, exploring pain relief in knee osteoarthritis and its unique mechanism of action.
third-news.com
April 24, 2025 at 6:31 AM
newsen.bsky.social
Sun Pharma Acquires Checkpoint Therapeutics to Enhance Oncology Offerings#India#Mumbai#Sun_Pharma#Checkpoint#UNLOXCYT
Sun Pharma Acquires Checkpoint Therapeutics to Enhance Oncology Offerings
Sun Pharma's acquisition of Checkpoint Therapeutics will enable better access to UNLOXCYT™, the first FDA-approved treatment for advanced skin cancer.
third-news.com
March 10, 2025 at 2:13 AM
newsen.bsky.social
ILUMYA® Proves Effective in Treating Moderate-to-Severe Nail Psoriasis: Insights from AAD 2025 Conference#USA#Princeton#Psoriasis#ILUMYA#Sun_Pharma
ILUMYA® Proves Effective in Treating Moderate-to-Severe Nail Psoriasis: Insights from AAD 2025 Conference
Recent research showcases the effectiveness of ILUMYA® (tildrakizumab-asmn) in alleviating nail psoriasis symptoms in a significant patient cohort. The study highlights its promising results presented at the 2025 AAD Conference.
third-news.com
March 7, 2025 at 2:31 PM